What's in Medicines Development for Global Health's pipeline?

Medicines Development for Global Health has 2 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Medicines Development for Global Health's portfolio?

Top competitors by shared drug class: Drugs for Neglected Diseases, University Hospitals Cleveland Medical Center.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/medicines-development-for-global-health.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Medicines Development for Global Health — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Medicines Development for Global Health pipeline: 0 marketed, 0 filed, 1 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
IDA - Ivermectin + DEC + albendazole	IDA - Ivermectin + DEC + albendazole	phase 3	Antiparasitic combination	GABA-gated chloride channels (ivermectin); β-tubulin (albendazole); microfilarial motility (DEC)	Infectious Disease / Parasitology

Therapeutic area mix

Infectious Disease / Parasitology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Drugs for Neglected Diseases · 1 shared drug class
University Hospitals Cleveland Medical Center · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Medicines Development for Global Health:

Cite this brief

Drug Landscape (2026). Medicines Development for Global Health — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/medicines-development-for-global-health. Accessed 2026-05-16.